S Leason
Impact in
- Epidemiology top 10%
- Acute Ischemic Stroke Management
- Neurology top 10%
- Intracerebral and Subarachnoid Hemorrhage Research
- Cerebrovascular and genetic disorders
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- Acute Ischemic Stroke Management 4
S Leason
9 papers receiving 549 citations
S Leason's Hit Papers
Peers
Comparison fields: 5 of 48
- Epidemiology 287
- Neurology 119
- Cardiology and Cardiovascular Medicine 138
- Internal Medicine 5
- Neurology 10
Countries citing papers authored by S Leason
This map shows the geographic impact of S Leason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Leason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Leason more than expected).
Fields of papers citing papers by S Leason
This network shows the impact of papers produced by S Leason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Leason. The network helps show where S Leason may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 193 | |
| 2 | 2017 | 130 | |
| 3 | 2022 | 84 | |
| 4 | Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial Hit paper breakdown → | 2024 | 78 |
| 5 | 2015 | 33 | |
| 6 | 2023 | 25 | |
| 7 | 2024 | 24 | |
| 8 | 2025 | 5 | |
| 9 | 2025 | 2 | |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 |
About S Leason
S Leason is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Neurology and Surgery, having authored 11 papers that have together received 574 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (4 papers), COVID-19 Clinical Research Studies (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), Intracerebral and Subarachnoid Hemorrhage Research (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Epidemiology (287 citations), Neurology (119 citations), Cardiology and Cardiovascular Medicine (138 citations), Internal Medicine (5 citations) and Neurology (10 citations). S Leason has collaborated with scholars based in United Kingdom, New Zealand and Norway. Their work appears in journals such as The Lancet, The Lancet Neurology, Neurology, EClinicalMedicine and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.